Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear distribution C pseudogene 1 (NUDCP1) is a pseudogene related to the nuclear distribution C (NUDC) gene. Pseudogenes are DNA sequences that resemble functional genes but are generally considered nonfunctional due to mutations or lack of regulatory elements required for expression[1][5]. While some pseudogenes in the human genome may be transcribed or even translated into peptides, most do not produce functional proteins and are not considered therapeutic targets[3][5]. There is no evidence in the literature or gene/protein databases that NUDCP1 encodes a druggable entity, is involved in disease biology, or is relevant as a biomarker or safety risk. No drugs or mechanisms of action are associated with this pseudogene, and it is not classified within recognized functional gene families such as receptors, enzymes, or transporters[1][4][5]. Additional Context: - The canonical functional gene, nuclear distribution C (NUDC), encodes a protein playing essential roles in mitosis and cytokinesis, particularly in spindle formation and microtubule organization[1][4]. - Pseudogenes like NUDCP1 are sometimes transcribed, and some can be translated at low levels[3][5]. However, translated peptides from pseudogenes are typically non-functional and not under strong evolutionary selection, with very limited biological relevance. - The majority of research, databases, and genomic resources do not register NUDCP1 as a biologically or medically relevant target. If you are seeking structured data on NUDCP1 as a therapeutic or biological target, the answer is that there is no suitable or actionable information—NUDCP1 is a pseudogene, not a protein, receptor, or druggable target[1][4][5]. If you intended to refer to the functional gene NUDC (nuclear distribution C), which is a protein-coding gene with established cellular functions, please clarify so relevant details for NUDC can be provided.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on nuclear distribution C pseudogene 1 (NUDCP1).